Tango Therapeutics Inc.
TNGX | NASDAQ
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$22.50
+$0.17 (+0.76%)
Pre-market:
Sep 22, 2026, 9:02 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 53.81M | 3.18M | 5.39M | 4.12M | 11.61M | 19.88M | 6.47M | 5.43M | 10.73M | 14.6M | 5.77M | 6.41M | 6.92M | 5.77M | 5.76M | 5.72M | 6.79M | 18.15M | 6.39M |
Cost of Revenue | n/a | 463K | 479K | n/a | 625K | n/a | n/a | n/a | n/a | n/a | n/a | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 577K | 21.92M | 462K | 446K |
Gross Profit | n/a | -463K | -479K | 53.81M | 2.56M | 5.39M | 4.12M | 11.61M | 19.88M | 6.47M | 5.43M | 10.12M | 13.09M | 4.31M | 4.96M | 5.7M | 5.09M | 5.09M | 5.14M | -15.14M | 17.69M | 5.94M |
Operating Income | -59.79M | -48.77M | -41.86M | 14.07M | -40.97M | -42.53M | -40.91M | -32.88M | -29.55M | -42.26M | -35.01M | -25.63M | -23.25M | -30.29M | -30.57M | -29.92M | -25.2M | -25.38M | -21.98M | -19.57M | -4.56M | -12.08M |
Interest Income | 3.72M | 2.18M | 1.68M | 1.1M | 1.24M | 1.61M | 1.81M | 1.81M | 2.07M | 2.2M | 2.24M | 1.87M | 1.45M | 1.06M | 591K | 350K | 297K | 218K | 196K | 91K | 104K | 104K |
Pretax Income | -55.34M | -45.51M | -38.8M | 15.87M | -38.82M | -39.84M | -37.62M | -29.11M | -25.49M | -37.87M | -30.72M | -22.24M | -20.65M | -28.01M | -29.01M | -29.05M | -24.86M | -25.21M | -21.87M | -19.53M | -4.51M | -12.03M |
Net Income | -55.34M | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M | -28.01M | -29.06M | -29.05M | -24.86M | -25.21M | -22.05M | -19.59M | -4.49M | -12.11M |
Selling & General & Admin | 22.59M | 15.24M | 9.76M | 8.92M | 11.34M | 11.48M | 11.09M | 11.22M | 10.77M | 10.66M | 9.11M | 8.6M | 7.67M | 6.56M | 6.44M | 6.88M | 6.55M | 6.14M | 5.49M | 4.43M | 3.17M | 3.02M |
Research & Development | 37.2M | 33.07M | 33.28M | 30.82M | 32.18M | 36.44M | 33.94M | 33.26M | 38.65M | 38.07M | 31.34M | 27.15M | 28.67M | 28.04M | 29.09M | 28.74M | 23.74M | 24.33M | 21.63M | 21.92M | 19.08M | 15M |
Other Expenses | n/a | n/a | -1.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -21.92M | n/a | n/a |
Operating Expenses | 59.79M | 48.31M | 41.39M | 39.74M | 43.52M | 47.92M | 45.03M | 44.49M | 49.43M | 48.73M | 40.44M | 35.75M | 36.34M | 34.59M | 35.53M | 35.62M | 30.29M | 30.47M | 27.12M | 4.43M | 22.25M | 18.02M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 59.79M | 48.77M | 41.86M | 39.74M | 44.15M | 47.92M | 45.03M | 44.49M | 49.43M | 48.73M | 40.44M | 36.36M | 37.85M | 36.05M | 36.98M | 36.84M | 30.97M | 31.14M | 27.7M | 26.36M | 22.71M | 18.47M |
Income Tax Expense | 1K | 1K | -55K | -10K | 35K | 34K | 49K | 54K | 65K | 40K | 47K | 23K | 64K | n/a | 51K | n/a | 3K | n/a | 177K | 62K | -21K | 74K |
Shares Outstanding (Basic) | 149.88M | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
Shares Outstanding (Diluted) | 149.88M | 143.58M | 116.17M | 110.97M | 110.54M | 110.3M | 108.68M | 108.51M | 108.31M | 108.17M | 95.8M | 97.03M | 88.35M | 88.19M | 87.97M | 87.89M | 87.84M | 87.67M | 87.57M | 70.16M | 87.47M | 87.47M |
EPS (Basic) | -0.37 | -0.32 | -0.30 | 0.14 | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 | -0.14 |
EPS (Diluted) | -0.37 | -0.32 | -0.30 | 0.14 | -0.35 | -0.36 | -0.34 | -0.27 | -0.24 | -0.35 | -0.32 | -0.23 | -0.23 | -0.29 | -0.33 | -0.32 | -0.28 | -0.29 | -0.25 | -0.28 | -0.05 | -0.14 |
EBITDA | -55.34M | -45.05M | -38.33M | 16.43M | -38.19M | -39.22M | -37M | -28.49M | -24.85M | -37.25M | -30.1M | -21.63M | -19.14M | -26.55M | -27.56M | -27.83M | -24.17M | -24.54M | -21.29M | -19.3M | -4.05M | -11.59M |
EBIT | -55.34M | -45.51M | -38.8M | 15.87M | -38.82M | -39.84M | -37.62M | -29.11M | -25.49M | -37.87M | -30.72M | -22.24M | -20.65M | -28.01M | -29.01M | -29.05M | -24.86M | -25.21M | -21.87M | -19.53M | -4.51M | -12.03M |
Depreciation & Amortization | n/a | 463K | 479K | 555K | 625K | 622K | 620K | 622K | 632K | 625K | 617K | 613K | 1.51M | 1.46M | 1.45M | 1.22M | 686K | 670K | 577K | 225K | 462K | 446K |
Add to Watchlist
Select watchlists to add or remove TNGX